Cargando…
Potential Role of Methotrexate Polyglutamates in Therapeutic Drug Monitoring for Pediatric Inflammatory Bowel Disease
Inside cells, the immunomodulator methotrexate (MTX) undergoes the addition of glutamates to form methotrexate polyglutamates (MTX-Glu)—promising biomarkers of systemic exposure and treatment response to MTX in rheumatology. MTX-Glu are underexplored in Inflammatory Bowel Disease (IBD), with no data...
Autores principales: | Morrow, Ryan, Funk, Ryan, Becker, Mara, Sherman, Ashley, Van Haandel, Leon, Hudson, Taina, Casini, Rebecca, Shakhnovich, Valentina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156207/ https://www.ncbi.nlm.nih.gov/pubmed/34069031 http://dx.doi.org/10.3390/ph14050463 |
Ejemplares similares
-
Methotrexate Polyglutamation in a Myasthenia Gravis Clinical Trial
por: Pasnoor, Mamatha, et al.
Publicado: (2020) -
Facing Real-World Challenges of Immunogenicity in Pediatric Inflammatory Bowel Disease
por: Gress, Kyle, et al.
Publicado: (2020) -
Factors associated with reduced infliximab exposure in the treatment of pediatric autoimmune disorders: a cross-sectional prospective convenience sampling study
por: Funk, Ryan S., et al.
Publicado: (2021) -
Differing contribution of methotrexate polyglutamates to adalimumab blood levels as compared with etanercept
por: Dervieux, Thierry, et al.
Publicado: (2019) -
A meta‐analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis
por: van de Meeberg, Maartje M., et al.
Publicado: (2022)